Thomas S Cunneen, Nigel Morlet. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » AdultFibrinolytic Agents/adverse effectsHumansMaleMyocardial Infarction/drug therapyRecombinant Proteins/adverse effectsRetrobulbar Hemorrhage/chemically inducedThrombolytic Therapy/adverse effectsTissue Plasminogen Activator/adverse effects
Substances: See more » Fibrinolytic AgentsRecombinant ProteinsreteplaseTissue Plasminogen Activator
Year: 2007 PMID: 17914052 DOI: 10.1056/NEJMc070824
Source DB: PubMed Journal: N Engl J Med ISSN: 0028-4793 Impact factor: 91.245